Patents/Assignees

PTC Therapeutics, Inc.

26 patents in portfolio

US11667596utility2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for Suppressing and Treating Alpha-synucleinopathies, Tauopathies, and Other Disorders
0 cites
US11638706utility2023
Methods for Treating Huntington's Disease
0 cites
US11613538utility2023
Method of Inhibiting or Reducing a Viral Infection
0 cites
US11608501utility2023
Methods for Modifying RNA Splicing
0 cites
US11602567utility2023
Methods for Modulating RNA Splicing
0 cites
US11560364utility2023
Methods for Enriching Alpha-tocotrienol from Mixed Tocol Compositions
0 cites

← PreviousPage 2 of 2